𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P025 MAINTENANCE Q8 THERAPY OF CROHN'S DISEASE WITH INFLIXIMAB IS ASSOCIATED WITH ENDOSCOPIC MUCOSAL HEALING IN THE LONG-TERM

✍ Scribed by F. Schnitzler; H. Fidder; M. Ferrante; M. Noman; G. Van Assche; I. Hoffman; S. Vermeire; P. Rutgeerts


Book ID
119637223
Publisher
Oxford University Press
Year
2008
Weight
70 KB
Volume
2
Category
Article
ISSN
1873-9954

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mucosal healing predicts long-term outco
✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 395 KB πŸ‘ 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients

Long-term outcome of maintenance inflixi
✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i